 Tilray Inc NASDAQ:TLRY shares are trading higher following news the company purchased a majority position in amended MedMen convertible notes for about 165.8 million. Irwin D. Simon, Tilrays Chairman and CEO, said, Backed by accelerating trends towards legalization globally, we are focused on building the worlds leading cannabis-focused consumer branded company with a goal of 4 billion of revenue by the end of our fiscal 2024. 